Literature DB >> 3207356

HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody.

L M Grimaldi1, R P Roos, S G Devare, J M Casey, Y Maruo, T Hamada, K Tashiro.   

Abstract

Human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM) and tropical spastic paraparesis belong to a new group of neurological diseases associated with retroviral infection. An HTLV-I-like virus has recently been implicated in multiple sclerosis as well. We studied paired cerebrospinal fluid and serum specimens from HAM and multiple sclerosis patients by isoelectric focusing and an isoelectric focusing HTLV-I p24 overlay technique to clarify the role of HTLV-I in these diseases. We detected oligoclonal bands by isoelectric focusing with silver-staining in cerebrospinal fluid, but not serum, from all 5 HAM and all 9 multiple sclerosis patients. An isoelectric focusing HTLV-I p24 overlay technique demonstrated anti-p24 antibody in HAM cerebrospinal fluid at a different pI distribution than that seen in paired serum, indicating local synthesis of anti-p24 antibody within the central nervous system. Oligoclonal bands in HAM cerebrospinal fluid corresponded in pI distribution to anti-p24 antibody activity, suggesting the presence of an ongoing HTLV-I infection in the central nervous system. Multiple sclerosis patients had no evidence of anti-HTLV-I activity by p24 radioimmunoprecipitation assay, Western immunoblots, or isoelectric focusing HTLV-I p24 overlay analysis. Our data support a role for HTLV-I as an etiological agent in HAM, but not in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207356     DOI: 10.1002/ana.410240606

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.

Authors:  Mohammad M Sajadi; George K Lewis; Michael S Seaman; Yongjun Guan; Robert R Redfield; Anthony L DeVico
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.

Authors:  B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame
Journal:  J Neurol       Date:  1996-05       Impact factor: 4.849

3.  Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

Authors:  Sabine Cepok; Dun Zhou; Rajneesh Srivastava; Stefan Nessler; Susanne Stei; Konrad Büssow; Norbert Sommer; Bernhard Hemmer
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

Review 4.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

5.  Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients.

Authors:  B Kitze; R W Turner; M Burchhardt; S Poser; G Hunsmann; T Weber
Journal:  Clin Investig       Date:  1992-11

6.  A Neuroprimer: Principles of Central Nervous System Immunity.

Authors:  Gregory P Owens
Journal:  Semin Pediatr Neurol       Date:  2017-08-14       Impact factor: 1.636

7.  Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV.

Authors:  Mark P Burgoon; Barbara N Hammack; Gregory P Owens; Amy L Maybach; M Judith Eikelenboom; Donald H Gilden
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

Review 8.  [New understanding of the immunopathogenesis of multiple sclerosis].

Authors:  B Rosche; B Kieseier; H-P Hartung; B Hemmer
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

9.  Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Raya Massoud; Izabela Bialuk; Kory R Johnson; Patrick L Green; Elizabeth M Maloney; Steven Jacobson
Journal:  Retrovirology       Date:  2013-02-13       Impact factor: 4.602

10.  Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patients.

Authors:  Luiz Claudio Pereira Ribeiro; Cassia Cristina Alves Gonçalves; Carla Maria Sena Andrade Slater; Silvia Maia Farias de Carvalho; Marzia Puccioni-Sohler
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-09       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.